# OnCo record paper-checkmate-204-n-engl-j-med-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-204-n-engl-j-med-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-204-n-engl-j-med-2018" ;
  schema:name "Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain"@en ;
  schema:description "Published report from the CheckMate 204 trial registered as NCT02320058, in New England Journal of Medicine (2018), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-204-n-engl-j-med-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1805453>, <https://pubmed.ncbi.nlm.nih.gov/30134131/>, <https://europepmc.org/article/MED/30134131>, <https://clinicaltrials.gov/study/NCT02320058> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1805453> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Tawbi HA, Forsyth PA, Algazi A, et al." ;
  onco:trials <https://onco.cc/trials/checkmate-204/> ;
  onco:journals <https://onco.cc/journals/nejm/> .